Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Littman

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Refu'At Ha-Peh Veha-Shinayim (Tel Aviv, Israel : 1969)|April 1, 1979
Pulp capping (a review)H Littman
The Journal of Rheumatology|August 1, 1989
Linear scleroderma: a response to neurologic injury? Report and literature reviewB H Littman
Personalized Medicine|May 23, 2018
Translational strategies to implement personalized medicine: rheumatoid arthritis examplesBruce H Littman
The Journal of Experimental Medicine|May 1, 1977
Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokinesB H Littman, S Ruddy
Arthritis and Rheumatism|March 1, 1982
Gold inhibition of the production of the second complement component by lymphokine-stimulated human monocytesB H Littman, P Schwartz
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Effects of vitamin D3 and IFN-gamma on the synthesis of the second complement component, C2, by a human myeloid leukemia (HL-60) cell lineB H Littman, K M Sanders
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1986
Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gammaK M Sanders, B H Littman
JAMA|March 13, 1978
Ibuprofen-induced meningitis in systemic lupus erythematosusH L Widener, B H Littman
Nature Reviews. Drug Discovery|August 2, 2005
The ultimate model organism: progress in experimental medicineBruce H Littman, Stephen A Williams
Journal of Translational Medicine|May 17, 2011
Create a translational medicine knowledge repository--research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?Bruce H Littman, Francesco M Marincola
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Refu'At Ha-Peh Veha-Shinayim (Tel Aviv, Israel : 1969)|April 1, 1979
Pulp capping (a review)H Littman
The Journal of Rheumatology|August 1, 1989
Linear scleroderma: a response to neurologic injury? Report and literature reviewB H Littman
Personalized Medicine|May 23, 2018
Translational strategies to implement personalized medicine: rheumatoid arthritis examplesBruce H Littman
The Journal of Experimental Medicine|May 1, 1977
Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokinesB H Littman, S Ruddy
Arthritis and Rheumatism|March 1, 1982
Gold inhibition of the production of the second complement component by lymphokine-stimulated human monocytesB H Littman, P Schwartz
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Effects of vitamin D3 and IFN-gamma on the synthesis of the second complement component, C2, by a human myeloid leukemia (HL-60) cell lineB H Littman, K M Sanders
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1986
Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gammaK M Sanders, B H Littman
JAMA|March 13, 1978
Ibuprofen-induced meningitis in systemic lupus erythematosusH L Widener, B H Littman
Nature Reviews. Drug Discovery|August 2, 2005
The ultimate model organism: progress in experimental medicineBruce H Littman, Stephen A Williams
Journal of Translational Medicine|May 17, 2011
Create a translational medicine knowledge repository--research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?Bruce H Littman, Francesco M Marincola
Pageof 3